Joshua Arbesman

7PUBLICATIONS
32CO-AUTHORS
Computational linguisticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 25, 2026
Evaluating Large Language Models for Melanocytic Lesion Pathology Report Interpretation.

|Jan 27, 2025
Patterns in progression from early-stage melanoma to late-stage melanoma: implications for survivorship follow-up.

David J Savage, Benjamin Switzer, Rujul Parikh

|Nov 30, 2023
Clinical and Immunologic Features of Germline Pathogenic Variant-Positive Patients with Melanoma.

Alan Shen, Michelle Arbesman, Roshan Lodha

|Sep 07, 2023
MC1R signaling through the cAMP-CREB/ATF-1 and ERK-NFκB pathways accelerates G1/S transition promoting breast cancer progression.

Vipin Shankar Chelakkot, Kiara Thomas, Todd Romigh

|Jan 26, 2023
AMPK Phosphorylates ZDHHC13 to Increase MC1R Activity and Suppress Melanomagenesis.

Yu Sun, Xin Li, Chengqian Yin

|May 10, 2020
Premature senescence in human melanocytes after exposure to solar UVR: An exosome and UV-miRNA connection.

Jingfeng Sha, Joshua Arbesman, Marian L Harter

Pageof 2

Frequent Collaborators

3 joint publications

Ying Ni

2 joint publications

Pauline Funchain

2 joint publications

Shuyang Chen

1 joint publications

Jingfeng Sha